Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0WZ3T
|
||||
| Former ID |
DNC012357
|
||||
| Drug Name |
1-(2-Pyridin-2-yl-ethyl)-3-thiazol-2-yl-thiourea
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C11H12N4S2
|
||||
| Canonical SMILES |
C1=CC=NC(=C1)CCNC(=S)NC2=NC=CS2
|
||||
| InChI |
1S/C11H12N4S2/c16-10(15-11-14-7-8-17-11)13-6-4-9-3-1-2-5-12-9/h1-3,5,7-8H,4,6H2,(H2,13,14,15,16)
|
||||
| InChIKey |
XNZLMIJCCHZKKA-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | HIV-1 reverse transcriptase | Target Info | Inhibitor | [1] | |
| References | |||||
| REF 1 | J Med Chem. 1995 Dec 8;38(25):4929-36.Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studiesof PETT analogs. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.